Abstract:OBJECTIVE:To evaluate the possibility and efficiency of nanoparticle as a new vector in vascular endothelial growth factor (VEGF) gene transference, and investigate the efficacy of direct gene transfer of nanoparticle with VEGF(165) gene into ischemic myocardium.METHODS:Nanoparticle-VEGF (Np/VEGF) complex was prepared with poly (D, L-lactide-co-glycolide) (PLGA) loading VEGF(165) gene and the envelopment efficiency and size of the complex were determined. The Np/VEGF was transfected into the cultured myocardial cells, RT-PCR and ELISA were used to evaluate the transfection of VEGF. Suspension of Np/VEGF was injected into the myocardial tissue of 4 rabbits. 96 hours after operation myocardial tissue was obtained, made into sections, and observed with electron microscope. New Zealand White rabbits underwent thoracotomy followed by ligation of left anterior descending coronary artery to establish ischemic models. The New Zealand White rabbits were divided into 3 groups: Np/VEGF group (n = 12, nanoparticle with VEGF(165) were injected into the cordial myocardium), blank plasmid group (n = 12, injected with blank VEGF(165) plasmid), and control group (n = 8, injected with normal saline). Ultrasonography and immunohistochemistry with factor VIII related antigen were conducted to evaluate the cardiac function and the collateral circulation of the occluded artery. One month later the rabbits were killed to observe the vascularization of capillaries in the ischemic myocardium.RESULTS:The envelopment efficiency of the Np/VEGF complex thus prepared, 50 - 300 nm in size, were 1.87% y. RT-PCR and ELISA showed that VEGF gene had been successfully transfected into myocardial cells by the nanoparticles. A great number of nanoparticles were observed in the myocardial cytoplasm and nuclei. One month after operation, the ventricular wall motor amplitude of the Np/VEGF group was 1.87 mm +/- 0.32 mm, significantly larger than those of the blank plasmid group (1.59 mm +/- 0.24 mm, P < 0.05) and control group (0.93 mm +/- 0.40 mm, P < 0.05); and the left ventricular ejection fraction of the Np/VEGF group was 60% +/- 10%, significantly higher than those of the blank plasmid group (50% +/- 6%, P < 0.05) and control group (40% +/- 8%, P < 0.05). The capillary density at low power field (x 100) of the Np/VEGF group was 57 +/- 12, significantly higher than those of the VEGF group (41 +/- 14) and control group (24 +/- 8).CONCLUSION:Nanoparticle can act as a vector to transfect specific gene in vitro and in vivo. Direct gene transfer of nanoparticle with DNA encoding VEGF into the ischemic rabbit myocardium can increase capillary number; therefore it may be a novel therapeutic approach for myocardial ischemia.

[The effect of vascular endothelia growth factor encapsulated in nanoparticles on chronic limb ischemia].

[Effect of Nanoparticle with Vascular Endothelial Growth Factor Gene Transferred into Ischemic Myocardium: Experiment with Rabbits].

Gene Transfer of Vascular Endothelial Growth Factor Reduces Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits.

"Molecular Bypass": The Application of vascular endothelial growth factor to gene therapy of experimental limb ischemia

Direct Intramuscular Injection of Psv-Vegf165 Stimulates Collateral Vessels Development in a Rabbit Model with Hindlimb Ischemia

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

Synergistic Effects of FGF-2 and PDGF-BB on Angiogenesis and Muscle Regeneration in Rabbit Hindlimb Ischemia Model

Intramuscular administration of vascular endothelial growth factor augmenting collateral circulation in a rat hindlimb replantation model.

The Therapeutic Effect of Vascular Endothelial Growth Factor Gene- or Heme Oxygenase-1 Gene-Modified Endothelial Progenitor Cells on Neovascularization of Rat Hindlimb Ischemia Model.

200. Factor VIII Gene Expression after Catheter-Based DNA Nanoparticle Delivery

Gene therapy by virus-like self-spooling toroidal DNA condensates for revascularization of hindlimb ischemia

Intramuscular Administration of Vascular Endothelial Growth Factor Augmenting Collateral Circulation in a Rat Hindlimb Replantation Model

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

Enhanced Collateral Growth by Double Transplantation of Gene-Nucleofected Fibroblasts in Ischemic Hindlimb of Rats

THERAPEUTIC ANGIOGENESIS BY INTRAMUSCULAR INJECTION OF FIBRIN PARTICLES INTO ISCHAEMIC HINDLIMBS

Efficient Delivery of VEGF-A mRNA for Promoting Diabetic Wound Healing via Ionizable Lipid Nanoparticles

Augmentation of Revascularization and Prevention of Plasma Leakage by Angiopoietin-1 and Vascular Endothelial Growth Factor Co-Transfection in Rats with Experimental Limb Ischaemia

Effects of Combined Angiopoietin-1 and Vascular Endothelial Growth Factor Gene Transfer on Neovascular Permeability of Rat Hindlimb Ischemia

Cell-mediated Delivery of VEGF Modified Mrna Enhances Blood Vessel Regeneration and Ameliorates Murine Critical Limb Ischemia.